Koichi Koizumi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Koichi Koizumi has a total of 86 co-authors. Here are the top co-authors by number of shared publications:
- Souichi Yanamoto
Department of Oral Oncology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
13 shared publications - Fumitaka Obayashi
Department of Oral Oncology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
11 shared publications - Sachiko Yamasaki
Department of Oral Oncology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
7 shared publications - Mirai Higaki
Division of Dentistry, Department of Oral Oncology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
6 shared publications Nanako Ito
6 shared publications- Nanako Ito
Department of Oral Oncology, Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan
6 shared publications
Latest Publications
- Open Access
- 11 August 2026
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology
Japanese clinical practice guidelines for Alluminox (photoimmunotherapy) treatment in oral cancer [English version of the Japanese Society of Oral Oncology clinical practice guidelines for Alluminox treatment (photoimmunotherapy) in oral cancer]
- 11 August 2026
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology
Open AccessJapanese clinical practice guidelines for Alluminox (photoimmunotherapy) treatment in oral cancer [English version of the Japanese Society of Oral Oncology clinical practice guidelines for Alluminox treatment (photoimmunotherapy) in oral cancer]
- Open Access
- 16 February 2026
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology
- Vol. 38 (5) , 863-868
Metastatic tumors in the oral and maxillofacial region: A multicenter retrospective investigation in Japan
- 16 February 2026
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology
- Vol. 38 (5) , 863-868
Open AccessMetastatic tumors in the oral and maxillofacial region: A multicenter retrospective investigation in Japan
- Open Access
- 27 November 2025
- Published by Wiley in Head & Neck
- Vol. 48 (4) , 1069-1076
Postoperative Adjuvant Therapy in Resectable Advanced Oral Squamous Cell Carcinoma With Intermediate Risk Factors
Background: Postoperative adjuvant therapy strategies are generally determined based on pathological risk stratification in oral cancer. However, the efficacy of postoperative adjuvant therapy in patients with intermediate‐risk factors for recurrence of oral cancer such as close surgical margins, pT3–T4 classification, pN2–N3 nodal status, perineural invasion, vascular invasion, lymphatic invasion and pattern of invasion remains unclear, and no standardized treatment guidelines or consensus have been established to date. Therefore, this study retrospectively analyzed the clinical significance of risk factors for pathological recurrence in patients with advanced oral cancer and evaluated the impact of postoperative adjuvant therapy on patient prognosis. Methods: This retrospective clinical study included 130 patients who underwent initial radical surgical resection for advanced oral squamous cell carcinoma (OSCC) at our institution between January 2010 and December 2023. The postoperative recurrence risk factors included ENE of the cervical lymph nodes, positive surgical margins, close surgical margins, pathological T classification (pT3 or pT4), pathological N classification (pN2 or pN3), metastasis to level IV or V lymph nodes, perineural invasion, vascular invasion, and lymphatic invasion. We analyzed the relationships among the presence of these risk factors, administration of postoperative adjuvant therapy (RT or CRT), occurrence of recurrence or metastasis, and patient prognosis (DFS). Results: Patients with lymphatic invasion had a significantly lower survival rate than those without lymphatic invasion (66.7% vs. 82.8%, p < 0.05). Although pT4, pN2–N3, perineural invasion‐positive and vascular invasion‐positive did not reach statistical significance, a trend toward reduced survival was observed in each case. The perineural invasion‐positive group had significantly higher recurrence and metastasis rates than the perineural invasion‐negative group (51.9% vs. 23.6%, p < 0.05). Multivariate analysis using logistic regression also confirmed the presence of perineural invasion as an independent prognostic factor (HR = 4.496, p = 0.019). Conclusions: This study demonstrated that perineural invasion is a significant risk factor for recurrence and that lymphatic invasion is a poor prognostic factor in oral cancer. Postoperative adjuvant therapy in patients with perineural or lymphatic invasion‐positive disease contributed to reduced recurrence rates and prolonged survival. These findings suggest that the pathological evaluation of perineural and lymphatic invasions is an important indicator in determining the appropriateness of postoperative adjuvant therapy.
- 27 November 2025
- Published by Wiley in Head & Neck
- Vol. 48 (4) , 1069-1076
Open AccessPostoperative Adjuvant Therapy in Resectable Advanced Oral Squamous Cell Carcinoma With Intermediate Risk Factors
Background: Postoperative adjuvant therapy strategies are generally determined based on pathological risk stratification in oral cancer. However, the efficacy of postoperative adjuvant therapy in patients with intermediate‐risk factors for recurrence of oral cancer such as close surgical margins, pT3–T4 classification, pN2–N3 nodal status, perineural invasion, vascular invasion, lymphatic invasion and pattern of invasion remains unclear, and no standardized treatment guidelines or consensus have been established to date. Therefore, this study retrospectively analyzed the clinical significance of risk factors for pathological recurrence in patients with advanced oral cancer and evaluated the impact of postoperative adjuvant therapy on patient prognosis. Methods: This retrospective clinical study included 130 patients who underwent initial radical surgical resection for advanced oral squamous cell carcinoma (OSCC) at our institution between January 2010 and December 2023. The postoperative recurrence risk factors included ENE of the cervical lymph nodes, positive surgical margins, close surgical margins, pathological T classification (pT3 or pT4), pathological N classification (pN2 or pN3), metastasis to level IV or V lymph nodes, perineural invasion, vascular invasion, and lymphatic invasion. We analyzed the relationships among the presence of these risk factors, administration of postoperative adjuvant therapy (RT or CRT), occurrence of recurrence or metastasis, and patient prognosis (DFS). Results: Patients with lymphatic invasion had a significantly lower survival rate than those without lymphatic invasion (66.7% vs. 82.8%, p < 0.05). Although pT4, pN2–N3, perineural invasion‐positive and vascular invasion‐positive did not reach statistical significance, a trend toward reduced survival was observed in each case. The perineural invasion‐positive group had significantly higher recurrence and metastasis rates than the perineural invasion‐negative group (51.9% vs. 23.6%, p < 0.05). Multivariate analysis using logistic regression also confirmed the presence of perineural invasion as an independent prognostic factor (HR = 4.496, p = 0.019). Conclusions: This study demonstrated that perineural invasion is a significant risk factor for recurrence and that lymphatic invasion is a poor prognostic factor in oral cancer. Postoperative adjuvant therapy in patients with perineural or lymphatic invasion‐positive disease contributed to reduced recurrence rates and prolonged survival. These findings suggest that the pathological evaluation of perineural and lymphatic invasions is an important indicator in determining the appropriateness of postoperative adjuvant therapy.
- 29 December 2024
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology
- Vol. 37 (4) , 607-616
Analysis of the molecular mechanism of claudin-1 expression in SCCKN cells, oral squamous cell carcinoma cell line
- 29 December 2024
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology
- Vol. 37 (4) , 607-616
Analysis of the molecular mechanism of claudin-1 expression in SCCKN cells, oral squamous cell carcinoma cell line
- 11 December 2024
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology
- Vol. 37 (4) , 788-792
Two cases of pediatric-onset orofacial granulomatosis
- 11 December 2024
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology
- Vol. 37 (4) , 788-792
Two cases of pediatric-onset orofacial granulomatosis
- 16 August 2024
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology
- Vol. 37 (2) , 365-370
A case of lymphoproliferative disease of the palate while receiving infliximab and azathioprine for Crohn's disease
- 16 August 2024
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology
- Vol. 37 (2) , 365-370
A case of lymphoproliferative disease of the palate while receiving infliximab and azathioprine for Crohn's disease
- Open Access
- 15 July 2024
- Published by Elsevier in Journal of Dental Sciences
- Vol. 20 (1) , 319-324
Potential effect of topical antibiotics administration in the oral cavity on the reduced number of bacteria entering the lower respiratory tract after oral cancer surgery
- 15 July 2024
- Published by Elsevier in Journal of Dental Sciences
- Vol. 20 (1) , 319-324
Open AccessPotential effect of topical antibiotics administration in the oral cavity on the reduced number of bacteria entering the lower respiratory tract after oral cancer surgery